Publication | Open Access
Proteasome Inhibition Measurements: Clinical Application
304
Citations
28
References
2000
Year
The described assay provides a reliable method for studying the pharmacodynamics of proteasome inhibitors and is now in use in concurrent phase I clinical trials with PS-341.
| Year | Citations | |
|---|---|---|
Page 1
Page 1